Nintedanib 150 mg . . .

NINTEDONE 150
Nintedanib (150mg)
Nintedanib is a medication used in the treatment of certain lung diseases, particularly idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILDs). It is available in various strengths, including 150 mg, and is typically administered orally in the form of capsules or tablets.

Here's some information about NINTEDONE 150 :

Indication: NINTEDONE 150 is primarily used for the treatment of idiopathic pulmonary fibrosis (IPF) and some other interstitial lung diseases (ILDs). IPF is a progressive lung disease characterized by the scarring (fibrosis) of lung tissue, which can lead to reduced lung function and difficulty breathing.

Mechanism of Action: NINTEDONE 150 is classified as a tyrosine kinase inhibitor. It works by targeting and inhibiting certain growth factors and signaling pathways involved in the formation of fibrotic tissue in the lungs. By doing so, it can slow down the progression of fibrosis and potentially improve lung function in some patients.

Dosage: The typical recommended dose of NINTEDONE 150 for the treatment of IPF is 150 mg taken orally, twice daily. The dosage and duration of treatment may vary depending on individual patient factors and the specific lung disease being treated. It's crucial to follow your healthcare provider's instructions regarding the dosage and treatment plan.

Side Effects: Like all medications, NINTEDONE 150 can cause side effects. Common side effects may include diarrhea, nausea, vomiting, abdominal pain, liver enzyme elevations, and decreased appetite. Some patients may experience more severe side effects, and it's essential to report any unusual or bothersome symptoms to your healthcare provider.

Monitoring: Patients prescribed Nintedanib may require regular monitoring of their lung function and blood tests to assess for any potential side effects or complications.

Precautions: Nintedanib may interact with other medications, and it may not be suitable for individuals with certain medical conditions. It's crucial to inform your healthcare provider about all the medications you are taking and your medical history before starting Nintedanib.

Duration of Treatment: The duration of Nintedanib treatment may vary based on the specific lung disease and individual patient response. It is often used as a long-term therapy to slow disease progression.

Nintedanib is a prescription medication, and its use should be supervised by a healthcare professional experienced in managing lung diseases. If you have been prescribed Nintedanib or have questions about its use, it's essential to discuss your treatment plan, potential benefits, and risks with your healthcare provider. They can provide you with personalized guidance based on your medical history and condition.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
sterisonline.com